Evidence map›Paper›PMID 39611026›Full record

ArticlePrecision chemistry2024

Pd-Catalyzed Stereospecific Glycosyl Cross-Coupling of Reversed Anomeric Stannanes for Modular Synthesis of Nonclassical

Guoqiang Cheng, Bo Yang, Yang Han, Wei Lin, Siyuan Tao, Yong Nian, Yingzi Li, Maciej A Walczak, Feng Zhu

Abstract read
In one paragraph

Article in Precision chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Site-Selective Distal Arylation of Sugars Enabled by Cyclic Acetals.Journal of the American Chemical Society · 2026
    Article
  2. Article
  3. Article
  4. Carbohydrate Synthesis is Entering the Data-Driven Digital Era.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Guoqiang ChengFrontiers Science Center for Transformative Molecules (FSCTM), Center for Chemical Glycobiology, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, Department of Chemical Biology, School of Chemistry and Chemical Engineering, Zhangjiang Institute for Advanced Study, Shanghai Jiao Tong University, Shanghai 200240, P. R. China.
Bo YangFrontiers Science Center for Transformative Molecules (FSCTM), Center for Chemical Glycobiology, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, Department of Chemical Biology, School of Chemistry and Chemical Engineering, Zhangjiang Institute for Advanced Study, Shanghai Jiao Tong University, Shanghai 200240, P. R. China.ORCID https://orcid.org/0000-0003-0612-5712
Yang HanFrontiers Science Center for Transformative Molecules (FSCTM), Center for Chemical Glycobiology, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, Department of Chemical Biology, School of Chemistry and Chemical Engineering, Zhangjiang Institute for Advanced Study, Shanghai Jiao Tong University, Shanghai 200240, P. R. China.
Wei LinSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P. R. China.ORCID https://orcid.org/0000-0002-2940-6966
Siyuan TaoSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P. R. China.ORCID https://orcid.org/0009-0005-1978-8787
Yong NianSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P. R. China.
Yingzi LiInstitute of Chemical Research of Catalonia (ICIQ), 43007 Tarragona, Spain.
Maciej A WalczakDepartment of Chemistry, University of Colorado Boulder, Boulder, Colorado 80309, United States.ORCID https://orcid.org/0000-0002-8049-0817
Feng ZhuFrontiers Science Center for Transformative Molecules (FSCTM), Center for Chemical Glycobiology, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, Department of Chemical Biology, School of Chemistry and Chemical Engineering, Zhangjiang Institute for Advanced Study, Shanghai Jiao Tong University, Shanghai 200240, P. R. China.ORCID https://orcid.org/0000-0003-3012-789X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonclassical

Identifiers

PMID39611026
PMCPMC11600346

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.